SETD2 and nonpapillary renal cell carcinoma: In ccRCC, an R1625C point mutation in SETD2 destabilizes SETD2 protein, reduces its capacity for substrate binding, diminishes H3K36me3, and delays the DNA damage response, with evidence of reduced γH2A.X foci formation in an H3K36me3-dependent manner.